Impaired Brain Energy Metabolism in the BACHD Mouse Model of Huntington's Disease: Critical Role of Astrocyte–Neuron Interactions

[1]  C. A. Toro,et al.  A failure in energy metabolism and antioxidant uptake precede symptoms of Huntington’s disease in mice , 2013, Nature Communications.

[2]  David Eidelberg,et al.  Metabolic network as a progression biomarker of premanifest Huntington's disease. , 2013, The Journal of clinical investigation.

[3]  Y. Chern,et al.  A critical role of astrocyte-mediated nuclear factor-κB-dependent inflammation in Huntington's disease. , 2013, Human molecular genetics.

[4]  M. Frosch,et al.  Elevated NADPH oxidase activity contributes to oxidative stress and cell death in Huntington's disease. , 2013, Human molecular genetics.

[5]  P. Detloff,et al.  Purkinje cell dysfunction and loss in a knock-in mouse model of Huntington Disease , 2013, Experimental Neurology.

[6]  R. Schreiber,et al.  Motor, emotional and cognitive deficits in adult BACHD mice: A model for Huntington's disease , 2013, Behavioural Brain Research.

[7]  A. Hannan,et al.  Hippocampal Neurogenesis, Cognitive Deficits and Affective Disorder in Huntington's Disease , 2012, Neural plasticity.

[8]  Jane S. Paulsen,et al.  8OHdG as a marker for Huntington disease progression , 2012, Neurobiology of Disease.

[9]  S. Small,et al.  R6/2 Huntington's Disease Mice Develop Early and Progressive Abnormal Brain Metabolism and Seizures , 2012, The Journal of Neuroscience.

[10]  M. Hayden,et al.  Marked differences in neurochemistry and aggregates despite similar behavioural and neuropathological features of Huntington disease in the full-length BACHD and YAC128 mice. , 2012, Human molecular genetics.

[11]  Pierre J Magistretti,et al.  Brain energy metabolism: focus on astrocyte-neuron metabolic cooperation. , 2011, Cell metabolism.

[12]  R. Swanson,et al.  Nuclear Factor Erythroid 2-Related Factor 2 Facilitates Neuronal Glutathione Synthesis by Upregulating Neuronal Excitatory Amino Acid Transporter 3 Expression , 2011, The Journal of Neuroscience.

[13]  J. Mauer,et al.  Mutant huntingtin causes metabolic imbalance by disruption of hypothalamic neurocircuits. , 2011, Cell metabolism.

[14]  Sarah A. Stern,et al.  Astrocyte-Neuron Lactate Transport Is Required for Long-Term Memory Formation , 2011, Cell.

[15]  Fanny Mochel,et al.  Energy deficit in Huntington disease: why it matters. , 2011, The Journal of clinical investigation.

[16]  J. Lucas,et al.  Protein oxidation in Huntington disease affects energy production and vitamin B6 metabolism. , 2010, Free radical biology & medicine.

[17]  M. MacDonald,et al.  Cholesterol Defect Is Marked across Multiple Rodent Models of Huntington's Disease and Is Manifest in Astrocytes , 2010, The Journal of Neuroscience.

[18]  Elena Cattaneo,et al.  Molecular mechanisms and potential therapeutical targets in Huntington's disease. , 2010, Physiological reviews.

[19]  S. Humbert,et al.  pARIS-htt: an optimised expression platform to study huntingtin reveals functional domains required for vesicular trafficking , 2010, Molecular Brain.

[20]  Marc Dhenain,et al.  Detection by voxel-wise statistical analysis of significant changes in regional cerebral glucose uptake in an APP/PS1 transgenic mouse model of Alzheimer's disease , 2010, NeuroImage.

[21]  M. Guillermier,et al.  In vivo expression of polyglutamine-expanded huntingtin by mouse striatal astrocytes impairs glutamate transport: a correlation with Huntington's disease subjects , 2010, Human molecular genetics.

[22]  Chuan-en Wang,et al.  Mutant Huntingtin in Glial Cells Exacerbates Neurological Symptoms of Huntington Disease Mice* , 2010, The Journal of Biological Chemistry.

[23]  N. Déglon,et al.  Mitochondria in Huntington's disease. , 2010, Biochimica et biophysica acta.

[24]  Chuan-en Wang,et al.  Expression of mutant huntingtin in mouse brain astrocytes causes age-dependent neurological symptoms , 2009, Proceedings of the National Academy of Sciences.

[25]  Carlos Cepeda,et al.  Full-Length Human Mutant Huntingtin with a Stable Polyglutamine Repeat Can Elicit Progressive and Selective Neuropathogenesis in BACHD Mice , 2008, The Journal of Neuroscience.

[26]  G. Egan,et al.  Magnetic resonance imaging as an approach towards identifying neuropathological biomarkers for Huntington's disease , 2008, Brain Research Reviews.

[27]  W. Frommer,et al.  GLUT1 and GLUT9 as major contributors to glucose influx in HepG2 cells identified by a high sensitivity intramolecular FRET glucose sensor. , 2008, Biochimica et biophysica acta.

[28]  Jane S. Paulsen,et al.  Thalamic metabolism and symptom onset in preclinical Huntington's disease. , 2007, Brain : a journal of neurology.

[29]  M. MacDonald,et al.  Unbiased Gene Expression Analysis Implicates the huntingtin Polyglutamine Tract in Extra-mitochondrial Energy Metabolism , 2007, PLoS genetics.

[30]  T. Videen,et al.  Selective defect of in vivo glycolysis in early Huntington's disease striatum , 2007, Proceedings of the National Academy of Sciences.

[31]  M. Beal,et al.  Oxidative damage in Huntington's disease pathogenesis. , 2006, Antioxidants & redox signaling.

[32]  Ji-Yeon Shin,et al.  Expression of mutant huntingtin in glial cells contributes to neuronal excitotoxicity , 2005, The Journal of cell biology.

[33]  M. Beal,et al.  The Energetics of Huntington's Disease , 2004, Neurochemical Research.

[34]  E. Welker,et al.  Glial Glutamate Transporters Mediate a Functional Metabolic Crosstalk between Neurons and Astrocytes in the Mouse Developing Cortex , 2003, Neuron.

[35]  R. Dantzer,et al.  Long‐term modulation of glucose utilization by IL‐1α and TNF‐α in astrocytes: Na+ pump activity as a potential target via distinct signaling mechanisms , 2002 .

[36]  R. Dantzer,et al.  Long-term modulation of glucose utilization by IL-1 alpha and TNF-alpha in astrocytes: Na+ pump activity as a potential target via distinct signaling mechanisms. , 2002, Glia.

[37]  Paolo Guidetti,et al.  Early Degenerative Changes in Transgenic Mice Expressing Mutant Huntingtin Involve Dendritic Abnormalities but No Impairment of Mitochondrial Energy Production , 2001, Experimental Neurology.

[38]  Marian DiFiglia,et al.  Huntington Disease , 1998, Journal of neuropathology and experimental neurology.

[39]  P Boesiger,et al.  Striatal glucose metabolism and dopamine D2 receptor binding in asymptomatic gene carriers and patients with Huntington's disease. , 1996, Brain : a journal of neurology.

[40]  P. Magistretti,et al.  Glutamate uptake into astrocytes stimulates aerobic glycolysis: a mechanism coupling neuronal activity to glucose utilization. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[41]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[42]  R. Ferrante,et al.  Neuropathological Classification of Huntington's Disease , 1985, Journal of neuropathology and experimental neurology.